Tang Capital Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.02M | Hold |
8,223,612
| – | – | 0.25% | 83 |
|
2025
Q1 | $6.21M | Buy |
8,223,612
+77,624
| +1% | +$58.6K | 0.34% | 67 |
|
2024
Q4 | $7.84M | Sell |
8,145,988
-70,972
| -0.9% | -$68.3K | 0.52% | 52 |
|
2024
Q3 | $11.8M | Hold |
8,216,960
| – | – | 0.85% | 40 |
|
2024
Q2 | $9.94M | Buy |
8,216,960
+1,809,560
| +28% | +$2.19M | 1.01% | 32 |
|
2024
Q1 | $15.1M | Buy |
6,407,400
+5,531,048
| +631% | +$13M | 1.57% | 20 |
|
2023
Q4 | $1.66M | Sell |
876,352
-350,000
| -29% | -$662K | 0.15% | 98 |
|
2023
Q3 | $1.68M | Sell |
1,226,352
-1,253,200
| -51% | -$1.72M | 0.24% | 76 |
|
2023
Q2 | $6.03M | Sell |
2,479,552
-40,448
| -2% | -$98.3K | 0.89% | 34 |
|
2023
Q1 | $14.5M | Buy |
2,520,000
+1,920,000
| +320% | +$11.1M | 2.16% | 15 |
|
2022
Q4 | $5.36M | Buy |
+600,000
| New | +$5.36M | 0.78% | 33 |
|